ReviewCureus2025
Mitral Regurgitation in Takotsubo Syndrome: A Comprehensive Narrative Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Takotsubo syndrome (TTS) is an acute, transient, non-ischemic cardiomyopathy marked by circumferential wall‑motion abnormalities that typically extend beyond a single epicardial territory. Although most patients recover left ventricular function within weeks, the acute phase can be destabilized by mechanical complications and cardiogenic shock. Mitral regurgitation (MR) in TTS is frequent and clinically consequential, arising from systolic anterior motion (SAM) with dynamic left ventricular outflow tract obstruction (LVOTO) or from leaflet tethering driven by apical or mid-ventricular ballooning in the absence of obstruction. These mechanisms demand divergent strategies because inotropes and afterload reduction that may help pump failure can aggravate obstruction, whereas preload reduction that aids congestion can worsen gradients if LVOTO is present. This review synthesizes epidemiology, mechanisms, imaging pathways, hemodynamic phenotypes, management, special contexts, outcomes, and research priorities of MR in TTS using only the provided peer-reviewed sources. Transthoracic echocardiography anchors diagnosis by identifying SAM, quantifying MR, and measuring left ventricular outflow tract (LVOT) or intracavitary gradients, while transesophageal echocardiogram (TEE), cardiovascular magnetic resonance imaging (CMR), left ventriculography, and myocardial contrast echocardiography (MCE) provide complementary insights when acoustic windows are limited or when postoperative differentials must be adjudicated. Right ventricular involvement denotes a higher‑risk phenotype with more functional regurgitation and worse short-term outcomes, reinforcing the need for meticulous preload and afterload management. In patients with obstruction, therapy focuses on beta-blockers, careful volume expansion, and vasoconstrictors to restore stability. For patients with tethering-dominant MR, the priority is decongestion and customized afterload reduction. If shock persists despite these measures, temporary mechanical circulatory support can be used to bridge patients to recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.